Cassava Sciences Inc (SAVA)

[investingdog]

From 10Q filing, page 28. :

P-values shown below are baseline vs. 6-month levels by paired t-test:
?
CSF biomarkers of disease pathology, t-tau and p-tau181, decreased 38% and 18%, respectively (both p<0.00001)
?
CSF biomarkers of neurodegeneration, neurogranin and neurofilament light chain (NfL), decreased 72% and 55%, respectively (both p<0.00001)
?
CSF biomarkers of neuroinflammation, sTREM2 and YKL-40, decreased 65% and 44% (both p<0.00001)